Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$165.7K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 8 most recent Form 4 transactions.
| Jul 11, 2025 | EYPT | EyePoint Pharmaceuticals,… | MEXER◆ | 2,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 11, 2025 | EYPT | EyePoint Pharmaceuticals,… | MEXER | 2,000 | — | — | +5.5% | Open the original filing on SEC.gov |
| May 19, 2025 | EYPT | EyePoint Pharmaceuticals,… | PBUY | 5,000 | $5.99 | $30K | +15.9% | Open the original filing on SEC.gov |
| May 16, 2025 | EYPT | EyePoint Pharmaceuticals,… | PBUY | 5,000 | $5.81 | $29.1K | +18.9% | Open the original filing on SEC.gov |
| May 15, 2025 | EYPT | EyePoint Pharmaceuticals,… | PBUY | 5,000 | $5.47 | $27.4K | +23.3% | Open the original filing on SEC.gov |
| May 14, 2025 | EYPT | EyePoint Pharmaceuticals,… | PBUY | 5,000 | $5.42 | $27.1K | +30.3% | Open the original filing on SEC.gov |